We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOP icon
1651
TOP Financial Group
TOP
$1.4B
$174K 0.01%
3,708
+3,690
+20,500% +$238K
PCOR icon
1652
Procore
PCOR
$8.67B
$174K 0.01%
2,675
+2,040
+321% +$120K
CRK icon
1653
Comstock Resources
CRK
$3.94B
$174K 0.01%
15,001
+6,839
+84% +$71.2K
ARCB icon
1654
ArcBest
ARCB
$3.08B
$173K 0.01%
1,756
+960
+121% +$85.8K
CIFR icon
1655
Cipher Digital
CIFR
$7.13B
$173K 0.01%
60,569
+57,443
+1,838% +$141K
PRTA icon
1656
Prothena Corp
PRTA
$450M
$173K 0.01%
2,535
+732
+41% +$47.2K
MCB icon
1657
Metropolitan Bank Holding Corp
MCB
$1.15B
$173K 0.01%
4,975
-932
-16% -$28K
RNAM
1658
DELISTED
Avidity Biosciences
RNAM
$173K 0.01%
15,570
+8,930
+134% +$112K
VSH icon
1659
Vishay Intertechnology
VSH
$5.43B
$173K 0.01%
5,869
+489
+9% +$12K
BIS icon
1660
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.1M
$173K 0.01%
4,140
+3,324
+407% +$132K
OR icon
1661
OR Royalties Inc
OR
$6.2B
$173K 0.01%
11,225
+7,101
+172% +$115K
NRG icon
1662
NRG Energy
NRG
$24.8B
$172K 0.01%
4,597
+132
+3% +$4.5K
ASB icon
1663
Associated Banc-Corp
ASB
$5.91B
$172K 0.01%
10,582
+1,514
+17% +$25K
UMDD icon
1664
ProShares UltraPro MidCap400
UMDD
$35M
$172K 0.01%
8,426
+103
+1% +$1.83K
ORGN
1665
DELISTED
Origin Materials
ORGN
$171K 0.01%
1,338
+1,249
+1,403% +$161K
BIO icon
1666
Bio-Rad Laboratories Class A
BIO
$9.42B
$171K 0.01%
451
-464
-51% -$189K
SKYY icon
1667
First Trust Cloud Computing ETF
SKYY
$3.12B
$171K 0.01%
2,249
-3,545
-61% -$244K
AGTI
1668
DELISTED
Agiliti Inc
AGTI
$171K 0.01%
10,350
+9,551
+1,195% +$160K
QDF icon
1669
FlexShares Quality Dividend Index Fund
QDF
$2.28B
$171K 0.01%
2,955
-1,567
-35% -$86.5K
PFBC icon
1670
Preferred Bank
PFBC
$1.25B
$171K 0.01%
3,105
+2,282
+277% +$115K
MTH icon
1671
Meritage Homes
MTH
$4.86B
$170K 0.01%
2,396
-52
-2% -$3.26K
VSTO
1672
DELISTED
Vista Outdoor Inc.
VSTO
$170K 0.01%
6,146
+4,197
+215% +$113K
ITCI
1673
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$170K 0.01%
2,684
+563
+27% +$35.1K
RDIV icon
1674
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
$170K 0.01%
4,342
-10,278
-70% -$403K
RYLD icon
1675
Global X Russell 2000 Covered Call ETF
RYLD
$1.39B
$170K 0.01%
9,387
-3,170
-25% -$57.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.